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Friedreich ataxia is a human neurodegenerative and myocardial
disease caused by decreased expression of the mitochondrial pro-
tein frataxin. Proteomic analysis of the mutant yeast model of Frie-
dreich ataxia presented in this paper reveals that these cells display
increased amounts of proteins involved in antioxidant defenses,
including manganese-superoxide dismutase. This enzyme shows,
however, lower activity than that found in wild type cells. Our
results indicate that this lack of activity is a consequence of cellular
manganese deficiency, because in manganese-supplemented cul-
tures, cell manganese content, and manganese-superoxide dis-
mutase activity were restored. One of the hallmarks of Friedreich
ataxia is the decreased activity of iron/sulfur-containing enzymes.
The activities of four enzymes of this group (aconitase, glutamate
synthase, succinate dehydrogenase, and isopropylmalate dehy-
dratase) have been analyzed for the effects of manganese supple-
mentation. Enzyme activities were recovered by manganese treat-
ment, except for aconitase, for which, a specific interaction with
frataxin has been demonstrated previously. Similar results were
obtained when cells were grown in iron-limited media suggesting
that manganese-superoxide dismutase deficiency is a consequence
of iron overload. In conclusion, these data indicate that generalized
deficiency of iron-sulfur protein activity could be a consequence of
manganese-superoxide dismutase deficiency, and consequently, it
opens new strategies for Friedreich ataxia treatment.
Friedreich ataxia (FRDA)3 is a human disease caused by decreased
expression of the mitochondrial protein frataxin due to the presence of
large expansions of a GAA triplet repeats in the first intron of the
nuclear gene coding for the protein (1). FRDA patients suffer frommul-
tiple symptoms, including progressive gait and limb ataxia, hyper-
trophic cardiomyophathy, and diabetes mellitus (2). These alterations
are thought to be the consequence of a mitochondrial defect related to
iron metabolism. However, although a large number of studies link
frataxin to iron metabolism, its precise function remains a matter of
debate. Frataxin has been suggested to play a role in iron-sulfur cluster
biosynthesis (3, 4), heme biosynthesis (5, 6), iron storage (7, 8), electron
transfer to ubiquinone (9), or holo-aconitase reconstitution (10, 11). In
hearts from FRDA patients, decreased activities of iron-sulfur-contain-
ing proteins and increased mitochondrial iron accumulation have been
reported (12). Furthermore, conditional knock-out mice in neuronal
and cardiac tissues have been developed as an animal model for FRDA.
Accordingly, this model displays iron accumulation and decreased
activity of iron-sulfur proteins (13). Consequently, some therapeutic
approaches under study suggest reducing the degree of iron accumula-
tion by chelators or prevent its prooxidant effects by the use of antioxi-
dants such as idebenone, a coenzyme Q analogue (2). Many studies on
frataxin function arise from experiments performed with the budding
yeast Saccharomyces cerevisiae (3, 6, 8, 9) as frataxin and the yeast
homologue Yfh1 are orthologues. Frataxin and Yfh1 are mitochondrial
proteins; the S. cerevisiaemutant in the YFH1 gene (yfh1) accumulates
iron and shows decreased activities of iron-sulfur-containing enzymes
(14); and finally, human frataxin complements yfh1 mutant strains
(15).
Despite the great amount of data obtained with these different model
systems, the analysis of the proteome of frataxin-deficient cells has not
been addressed. Thus, we have focused on the effects of the absence of
frataxin on the cellular proteome of yeast. One of the major findings is
that, although the amount of the antioxidant enzymemanganese-super-
oxide dismutase (Mn-SOD) is increased, its activity is decreased in
yfh1 cells. This deficiency contributes to lowered activities of several
iron-sulfur-containing enzymes, one of the hallmarks of Friedreich
ataxia.
EXPERIMENTAL PROCEDURES
Organisms and Culture Conditions—S. cerevisiae W303 and its iso-
genic null yfh1 derivative (MML298) were kindly provided by Dr.
Enrique Herrero from the Universitat de Lleida (16). Strains BY4741
and Y02769 (grx5 in BY4741 backgound) were provided by EURO-
SCARF (Frankfurt, Germany). The YFH1 gene used in complementa-
tion studies was also obtained from the EUROSCARF collection. It car-
ries upstream and downstream regulatory sequences and is cloned in
pRS416, an ARS-CEN-URA vector. Yeast cells were grown in rich
medium (1% yeast extract, 2% peptone) with either 2% glucose (YPD) or
3% glycerol (YPG) by incubation in a rotary shaker at 30 °C. Raffinose
synthetic medium contained 2% raffinose, 0.67% yeast nitrogen base
(Difco), 0.25% ammonium sulfate, a mixture of amino acids, and the
required auxotrophic supplements (17). Theyfh1mutant transformed
with pRS416-YFH1 plasmid was maintained in synthetic mediumwith-
out uracil. Before each experiment the strain was transferred to rich
medium for 4–5 generations.
Two-dimensional Gel Electrophoresis—Cells were resuspended in 25
mMTris-HCl buffer, pH8, plus 8Murea and disrupted using glass beads.
An equal volume of 8 M urea, 8% CHAPS, and 50 mM dithiothreitol was
added to the lysed cells, and after centrifugation (12,000 rpm for 5 min)
10 l of the supernatant were diluted in 350 l of rehydration buffer
(18). Isoelectric focusing was performed in immobilized pH gradient
strips (3–10 NL; Bio-Rad). Second dimension SDS-PAGE was per-
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formed on 12.5% polyacrylamide gels. Gels were scanned in a GS800
densitometer (Bio-Rad) and analyzedwith PDQuest software (Bio-Rad).
Analyses—Total cellular iron was determined under reducing condi-
tions with bathophenanthroline sulfonate as chelator (19). Manganese
content was assayed in a graphite furnace atomic absorption spectro-
photometer. Superoxide ion levels were measured in a spectrofluoro-
photometer (RF-5000, Shimadzu). Exponentially growing cells were
washed in water and resuspended in phosphate-buffered saline plus
0.1% glycerol and 5 g/ml the superoxide specific probe dihydro-
ethidium (DHE) (Fluka) (20). The rate of oxidation of DHE was calcu-
lated from the rate of increase in fluorescence for 30min (excitation 520
nm, emission 590 nm).
Enzyme Activities—Cell extracts were prepared using glass beads and
assayed as described in the following references: aconitase and succinate
dehydrogenase (16), glutamate synthase (21), isopropylmalate dehy-
dratase (22), superoxide dismutase (23).
Western Blot Analysis—Cell extracts were separated in SDS-poly-
acrylamide gels and transferred to polyvinylidene difluoride mem-
branes. Antibodies against superoxide dismutases were from Stress-
Gene (SOD-111,Mn-SOD) and fromChemicon (AB1237, CuZn-SOD).
Anti-Aco1 aconitase (from R. Lill, Marburg, Germany) and anti-succi-
nate dehydrogenase (from B. Lemire, University of Alberta) antibodies
were also used. A peroxidase-conjugated anti-rabbit antibody was used
for detection. Image acquisition was performed in a ChemiDoc CCD
camera (Bio-Rad).
RESULTS
Analysis of the Proteome of yfh1 Cells by Two-dimensional
Electrophoresis—Tissues affected in FRDA are those with elevated oxi-
dative metabolism, like heart and nervous system (2). Thus, unless oth-
erwise stated, our experiments were carried out on yeast cells grown in
rich medium containing glycerol (YPG), because in this medium cells
exhibit high respiration rates. It is worth mentioning that the ability of
this strain to grow in a non-fermentable carbon source such as glycerol
has been described previously (24–26). Wild type and yfh1 cells were
harvested during exponential phase and the crude extracts analyzed by
two-dimensional gel electrophoresis (Fig. 1). Spots that repetitively
showed at least 2-fold difference in protein amount between both
strains were identified and are shown in Table 1. Similar results were
found in cells grown on rich medium containing glucose (YPD) (Fig. 2).
Cells deficient in YFH1 clearly exhibit increased amounts of enzymes
involved in the oxidative stress response. Among these proteins, four
thiol peroxidase isoenzymes have been identified. These enzymes elim-
inate H2O2 and alkyl hydroperoxides with the use of thioredoxin and
thioredoxin reductase as thiol-reducing donor (27), two proteins that
are also induced in yfh1 cells. Two additional enzymes involved in the
oxidative stress response that have been identified are both mitochon-
drial and cytosolic SODs. These enzymes catalyze the dismutation of
superoxide into O2 and H2O2 (28). The increased expression of these
eight proteins indicates an endogenous situation of oxidative stress in
yfh1 cells. It is interesting tomention that no changes in the expression
TABLE 1
Proteins identified differentially expressed in wild type and
yfh1 cells
Spots showing a minimum of 2-fold difference in protein abundance between wild
type and yfh1 proteomes (see Figs. 1 and 2) were digested with trypsin and ana-
lyzed in anApplied BiosystemsVoyager DE PROMALDI-TOF. Proteins were iden-
tified by peptide mass fingerprinting with MASCOT. Percent protein coverage for
each spot in the MASCOT analysis is shown. Fold induction (yfh1 over wild type,
mean of three independent experiments  S.E.) was estimated considering all the
spots identified as the sameprotein. The valueswith the symbol are estimated and
indicate that a corresponding spot in the wild-type sample is too low to be used as a
reference value.
Protein Gene Spots Coverage Fold inductionYPD YPG
%
Thiol peroxidase 1 TSA1 7 30.6 10.6 3.1 7.1 3.0
8 50.2
Thiol peroxidase 2 TSA2 13 13.4 21.0 14.0





Thioredoxin reductase TRR1 1 37.7 25.0 20.0
Thioredoxin 1 TRX2 15 37.8 3.9 0.2 14.7 4.5
Mitochondrial thiol
peroxidase
PRX1 6 30.3 5.3 0.4 8.3 0.6
CuZn-superoxide dismutase SOD1 14 70.0 5.5 0.3 4.0 0.3
Manganese-superoxide
dismutase
SOD2 5 42.0 4.0 0.9 3.0 0.3
Triosephosphate isomerase TPI1 2 22.7 1.9 0.3 4.6 0.9
4 66.2
Adenylate kinase ADK1 3 35.6 2.1 0.3 2.9 1.3
FIGURE 1.Analysis of the proteome ofwild type
and yfh1 cells by two-dimensional gel elec-
trophoresis. W303 (wild type) and the isogenic
derivative yfh1 (MML298) cells were grown in
YPG medium, and 40 g of total cell lysates were
separated by two-dimensional gel electrophore-
sis. Gels were silver-stained and analyzed with
PDQuest software (Bio-Rad).
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of antioxidant enzymes were observed by gene expression analysis of
yfh1mutant cells using DNAmicroarrays (25), even though the strain
used had the same genetic background in both studies. A partial expla-
nation to this fact is that, in the reference cited, many of the induced
genes code for membrane proteins that are poorly resolved in two-
dimensional gels. Furthermore, lack of concordance between proteomic
and transcriptomic analysis is not unusual (29), thus highlighting the
importance of both approaches.
Manganese andMn-SODDeficiency inyfh1 Cells—Among the pro-
teins induced in yfh1 cells, both SODs were found. This result was
further confirmed by Western blotting using specific antibodies (Fig.
3A). Interestingly, when the enzymatic activity of Mn-SOD (coded by
SOD2) was analyzed, we found that in yfh1 cells it was lower than in
wild type cells (Fig. 3,A andB). The decreasedMn-SODactivity resulted
in increased steady state levels of superoxide anion inside yeast cells. As
shown in Fig. 3C, the rate of oxidation of DHE, a superoxide-specific
probe, is increased by 2-fold in YFH1-deficient cells.
Trying to unravel the cause of Mn-SOD deficiency in yfh1 cells, we
first analyzed the manganese content of wild type and yfh1 cells. As
shown in Fig. 4A, manganese concentration in the latter was 20% of that
found in wild type cells, suggesting that manganese transport could be
altered in that strain. To further confirm that this altered phenotype is a
consequence of YFH1 deficiency, we transformed the yfh1 strain with
a plasmid containing the YFH1 gene with its own promoter (see “Exper-
imental Procedures”), and transformants (yfh1-YFH1) were analyzed
for the altered parameters. As shown in Fig. 3A, Mn-SOD activity, as
well as Sod1 and Sod2 protein levels, were restored. Also, yfh-YFH1
cells displayedmanganese and iron concentrations close to those found
in wild type cells (Fig. 4A).
Recovery of Mn-SOD Activity by Manganese Treatment—The results
described above suggested that intracellular manganese and Mn-SOD
activity inyfh1 could be reestablished by supplementing growthmedia
with this metal. To this purpose, yfh1 cell cultures were treated with
increasing concentrations of MnCl2. As shown in Fig. 4B, manganese
levels were restored. Consistently, recovery of Mn-SOD activity in a
dose-dependent manner was also observed (Fig. 3A). Thus, lack of Mn-
SOD activity in yfh1 cells is a consequence of cellular manganese defi-
ciency. In accordance with these results, a clear decay in superoxide
anion levels was observed in yfh1 cells grown in manganese-supple-
mented media, and the values were indistinguishable from those of the
FIGURE 3. Decreased superoxide dismutase activity in yfh1 and effect of manga-
nese supplementation. A, cultures of wild type,yfh1,yfh1-YFH1, andyfh1 plus 100
MMnCl2 were grown in YPGmedium, and cell lysates (20g of protein) were analyzed
by native gel electrophoresis and SODactivity staining.Western blot analysis of total cell
extracts against Sod1 and Sod2 was performed under denaturing conditions; B, wild
type (white bars) and yfh1 cells (gray bars) were grown in YPG medium supplemented
with the indicatedamountsofMnCl2. Cell lysateswere analyzed for SODactivity innative
gels. Bands corresponding to Mn-SOD were measured with a densitometer and the
relative density calculated (QuantityOne software, Bio-Rad);C, wild type (white bars) and
yfh1 cells (gray bars) were grown in YPG medium supplemented with the indicated
amounts of MnCl2 and analyzed for the rate of oxidation of DHE by endogenous super-
oxide. Data are represented as means S.E. from three independent experiments.
FIGURE 2.Analysis of the proteome ofwild type
and yfh1 cells grown in YPD by two-dimen-
sional gel electrophoresis.W303 (wild type) and
the isogenic derivativeyfh1 (MML298) cells were
grown in YPD medium, and 40 g of total cell
lysates were separated by two-dimensional gel
electrophoresis. Gels were silver-stained and ana-
lyzed with PDQuest software (Bio-Rad).
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wild type cells (Fig. 3C). Nevertheless, as shown in Fig. 4C, manganese
treatment had no significant effect on total cellular iron concentration,
both in wild type or yfh1 cells.
Recovery of Iron-Sulfur Enzymes byManganese Treatment—Frataxin
has been suggested to play an important role in iron-sulfur cluster bio-
synthesis. This hypothesis is based on the decreased activities of iron-
sulfur enzymes found in frataxin-deficient cells (12) and a physical and
genetic interaction with Isu1, a scaffold protein required for iron-sulfur
clusters biogenesis (3, 4). However, decreased activities of iron-sulfur
enzymes have been observed in yeast lacking SOD2 (30) and in Mn-
SOD knock-out mice (31). In this context, our results suggest that a
decline in iron-sulfur enzyme activities in yfh1 cells could be a conse-
quence of oxidative stress in mitochondria due to decreased Mn-SOD
activity. To test this hypothesis, we analyzed activities of three iron-
sulfur mitochondrial enzymes (aconitase, glutamate synthase, and
succinate dehydrogenase) and a cytosolic one (isopropylmalate
dehydratase) in wild type and yfh1 cells grown in manganese-supple-
mented YPG (Fig. 5). Values of iron-sulfur enzyme activities in yfh1
cells are in agreement to those described by other authors (9, 17, 26, 32)
With the exception of aconitase, all other enzyme activities analyzed
showed a clear recovery bymanganese treatment, indicating that lack of
Mn-SOD activity contributes to inactivating these enzymes. Also, these
results suggest that YFH1 is not essential for iron-sulfur biosynthesis,
except for aconitase. Such an exception can be explained by recent
observations reporting that frataxin interacts with aconitase and that
such interaction is crucial for reconstitution of the aconitase [4Fe4S]
cluster (10, 11).
Recovery of Iron-Sulfur Enzymes andMn-SOD in Iron-limitingMedia—
In a previous work published by Foury’s group (17), it was found that
succinate dehydrogenase, but not aconitase activity, could be rescued
whenyfh1 yeast cells were grown in iron-limitedmediumusing batho-
phenanthroline sulfonate (BPS) as iron chelator. In such conditions,
cellular iron accumulation is prevented. To test whether such treatment
is also capable of restoring iron-sulfur enzymes other than succinate
dehydrogenase, wild type and yfh1 cells were grown in raffinose syn-
theticmedium supplementedwith BPS (Fig. 6). The results obtained not
only confirmed the findings reported by Foury but also showed that
isoprpopylmalate dehydratase and Mn-SOD activities were recovered
in such conditions. These are additional indications that decreased
Mn-SOD activity leads to inactivation of iron-sulfur containing
enzymes in yfh1 cells.
Manganese and Mn-SOD Deficiency Are the Consequence of Iron
Overload—As shown above, yfh1 cells displayed low levels of manga-
nese that caused decreased activities of several iron-sulfur containing
enzymes. This phenotype was corrected by manganese supplementa-
tion. Nevertheless, iron accumulation, induction of Sod1 and Sod2 (Fig.
3A), and slow growth in YPG (data not shown) persisted in manganese-
treatedyfh1 cells, suggesting that they are not strictly a consequence of
manganese deficiency. Then, could manganese deficiency be a conse-
quence of iron accumulation caused by the absence of Yfh1? The exper-
iments in iron-limitedmedia support this hypothesis, becauseMn-SOD
activity is restored when iron accumulation is prevented in yfh1 cells
(Fig. 6). To study whether this phenotype is a more general phenome-
non and not restricted to the mutant strain used, we further checked
this hypothesis by analyzing manganese content and SOD activity in a
strain with altered iron homeostasis such as a yeast mutant lacking
FIGURE 4. Total cellular manganese and iron concentrations of wild type, yfh1,
and yfh1-YFH1 cells. A, wild type (white bars) yfh1 cells (gray bars) and yfh1-YFH1
(black bars) cells were grown in YPG medium. Manganese and iron content were quan-
tified as described under “Experimental Procedures.” B, wild type (white bars) andyfh1
cells (gray bars) were grown in YPGmedium supplemented with the indicated amounts
of MnCl2 and analyzed for total cellular manganese. The same experiment was per-
formed to analyze total cellular iron (C). Data are represented asmeans S.E. from three
independent experiments.
FIGURE 5.Activities of iron-sulfur-containing proteins in wild type andyfh1 yeast
cells. Wild type (white bars) and yfh1 cells (gray bars) were grown in YPG medium
supplemented with increasing amounts of MnCl2. A, enzymatic activities of glutamate
synthase, aconitase, succinate dehydrogenase (SDH), and isopropylmalate dehydratase
(IMD) in whole cell extracts; B, no changes in the amounts of aconitase and succinate
dehydrogenase were found in Western blot analysis of total cell extracts against Aco1
and Sdh2. Data are represented as means S.E. from three independent experiments.
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GRX5.Mutants deficient in this glutaredoxin exhibit a strong iron accu-
mulation, aswell as decreased activities in aconitase and succinate dehy-
drogenase (16). As shown in Fig. 7A, manganese levels in this strainwere
60% of those found in wild type cells, in agreement with the data
obtained in yfh1 mutant strain. Also, grx5 cells exhibit an 80%
decrease in Mn-SOD activity. In this case, this activity can also be
restored by manganese supplementation (Fig. 7B). Taken together, the
data obtained from both mutant strains clearly suggest that manganese
deficiency would be a side effect of iron accumulation.
DISCUSSION
The precise role of frataxin in ironmetabolism is a hot field of discus-
sion. Themost accepted hypothesis is that it cooperates in iron delivery
to Isu1, a scaffold protein required for iron-sulfur biogenesis. However,
it has been suggested that the role of frataxin would be non-essential in
such process (26). Moreover, recent data support this hypothesis: (i)
frataxin interacts much more strongly with ferrochelatase than with
Isu1 (5); (ii) in Escherichia coli, IscA (homologous to Isa1 and Isa2 in
yeast) is the iron donor to IscU (homologous to Isu1 in yeast), and
frataxin homologues are not required for the biogenesis of iron-sulfur
clusters (33); and (iii) a direct interaction between frataxin and aconitase
has been reported (10, 11). The results shown in this paper clearly indi-
cate that frataxin is not essential for iron-sulfur cluster biogenesis
(although required for full recovery of aconitase activity) and give a
reasonable explanation of how the absence of frataxin leads to iron-
sulfur deficiency in the yeast model of FRDA. Iron overload would lead
to reduced manganese levels that would result in impaired manganese
incorporation into Sod2. Lack of Mn-SOD activity would result in
increased levels of superoxide (Fig. 3C) that would inactivate iron-
sulfur-containing enzymes. The link between iron accumulation and
Mn-SOD deficiency is clearly established with the experiments per-
formed with BPS and grx5 cells. Also, a direct link between Mn-SOD
activity and inactivation of iron-sulfur enzymes arises from experiments
reported in Figs. 5 and 6. Results shown in Fig. 5 demonstrate the recov-
ery of Mn-SOD and iron-sulfur containing enzymes by manganese
treatment. In this context, it is worth mentioning that manganese
itself has antioxidant properties that suppress growth defects in a
sod1sod2 mutant (34). However, this suppression required concen-
trations above 2mM andwas not observed at concentrations used in our
work (50–100M). Consistently, when we treated asod2mutant with
100 M manganese, recovery of iron-sulfur enzymes was not observed
(data not shown). Furthermore, as shown in Fig. 6, enzyme activities
were recovered by reducing iron concentration (without manganese
supplementation). Consequently, it is not likely that recovery of iron-
sulfur enzymes could be a consequence of the antioxidant properties of
manganese independently of Mn-SOD recovery.
An important problem to solve in the future is how iron overload
results in manganese deficiency. As a hypothesis, it should be men-
tioned that Smf2p, a high affinity manganese transporter, could be the
link. Cells lacking SMF2, as those lacking YFH1, show decreased man-
ganese content and limited Mn-SOD activity. These defects are cor-
rected after manganese supplementation of growth media (23). Inter-
estingly, Smf2 activity is decreased at the post-translational level by
elevated iron levels and its expression is not regulated by the iron sensor
Aft1 (35). Thus, in contrast to Aft1, Smf2 could be able to sense
increased iron levels in yfh1 cells and lead to decreased high affinity
manganese transport. It is worthmentioning thatmanganese deficiency
linked to increased iron levels could be a general situation not only
applying to FRDA. The results obtained with grx5 mutant cells indi-
cate that these could be a more general phenomena occurring in iron
overloading diseases. An important consequence is that oxidative stress
triggered by an excess of iron would be potentiated by diminished SOD
activities.
As mentioned earlier, our work supports that Yfh1 should be dispen-
sable for iron-sulfur cluster biogenesis. However, how lack of Yfh1
induces iron accumulation in yeast is still an intriguing question. Iron
accumulation in yfh1mutants depends on constitutive activation of the
iron sensor Aft1 (25), and it has been reported that this sensor responds
to a signal connected to mitochondrial iron-sulfur cluster biogenesis
(36). As shown in Fig. 5, manganese treatment restores the activity of
some iron-sulfur enzymes, but iron overload persists. This indicates
that the signal acting on Aft1 is not restored in these particular circum-
stances. Could this signal be related to aconitase? It should be kept in
mind that in manganese-treated yfh1 cells, its activity is not restored,
and according to two recent reports (10, 11), reconstitution of the acon-
itase [4Fe4S] cluster depends on its interaction with frataxin. Also, in
mammals, cytosolic aconitase (Irp-1) has a well known role as an iron
sensor (37). In yeast, apo-aconitase binds to mitochondrial DNAwhere
it could play a regulatory function in response to changing metabolic
needs (38).
Another important conclusion from this work arises from the analy-
FIGURE 6. Activities of Mn-SOD and iron-sulfur containing proteins in yfh1 yeast
cells grown in iron-limitedmedium.Wild type andyfh1 cells were grown in raffinose
synthetic medium supplemented (black bars) or not (white bars) with 10 M BPS. Iron
content and enzymatic activities in yfh1 cells (relative to wild type grown in the same
conditions) are shown. In iron-limited medium (plus BPS), Mn-SOD, succinate dehydro-
genase (SDH), and isopropylmalate dehydratase (IMD) activities were recovered; iron
accumulation was prevented; and aconitase activity was not restored. Data are repre-
sented as means S.E. from three independent experiments.
FIGURE 7. Manganese deficiency and decreased superoxide dismutase activity in
grx5. BY4741 (wild type,white bars) and its isogenic derivativegrx5 (black bars) were
grown in YPD medium supplemented with increasing amounts of MnCl2. A, whole cell
manganese concentration was quantified as described under “Experimental Proce-
dures”; B, 40 g of cell lysates were loaded on native gels. Bands corresponding to
Mn-SODweremeasured with a densitometer and the relative density calculated (Quan-
tity One software). Data are represented as means  S.E. from three independent
experiments.
Manganese Deficiency in Friedreich Ataxia


















sis of the proteome of yfh1 cells. Induction of antioxidant defenses
reveals that YFH-deficient cells are exposed to an endogenous oxidative
stress. This would be the consequence of Mn-SOD deficiency but more
importantly of iron overload, since the increased amounts of Sod1p and
Sod2p persisted in manganese-treated yfh1 cells. The relevance of
oxidative stress in FRDA is also a matter of discussion. Markers of
oxidative stress in samples of FRDA patients have been extensively
reported; for instance, in lymphoblasts, mitochondrial peroxides were
increased and the GSH/GSSG ratio was reduced (39); in fibroblasts, the
GSH/GSSG ratio decreased by 3-fold and protein-bound glutathione
and actin glutathionylation were increased (40). On the other hand, the
existence of oxidative stress in FRDA has been questioned by some
reports that were unable to identify markers of oxidative stress, like
protein-bound carbonyl groups (41) or malondialdehyde (42), in differ-
ent FRDA models. But it should be kept in mind that specific targets
depend on how oxidative stress is generated (43, 44). This means that
the absence of a specific marker of oxidative stress in one system does
not preclude the presence of oxidative stress in such system.
Finally, the results shown here open the question on whether man-
ganese and deficient SOD activity are both related to FRDA. Alterations
in SOD activity and expression have been reported in other FRDAmod-
els. Embryonic mouse cells treated with retinoic acid and frataxin anti-
sense RNA show increased expression ofMn-SOD compared with con-
trol cells. Retinoic acid induces differentiation of embryonic cells into
neurons, astroglia, andmicroglia (45). According to a recent report (46),
fibroblasts and lymphoblasts from FRDA patients could have decreased
antioxidant capacity. Decreased total SOD activity is observed in hearts
from the mouse model of FRDA ataxia (47). In this model, Mn-SOD
expression increases after birth and suddenly drops after 10 weeks (41).
Could this drop in Mn-SOD expression be the consequence of manga-
nese deficiency? Interestingly, Smf2p is homologous to DMT1, which
transports iron as well as manganese inmammals (48). The existence of
amanganese deficiency in FRDApatients could lead to a sudden change
in FRDA therapies. Manganese is known to be essential for the devel-
opment and function of the brain. Manganese-deprived rats are often
ataxic (49). The reason is not known, but it is remarkable that several
brain manganese-containing enzymes, such as glutamine synthetase,
pyruvate carboxylase, or Mn-SOD, play a significant role in brain func-
tion and could be affected by manganese deficiency. Should manganese
supplementation be considered in FRDA patients? Even if such defi-
ciency is confirmed in mammals, this is a delicate point, since high
environmental exposure to manganese has toxic effects. However, oral
manganese intake is considered to be safe even at concentrations 5-fold
above the recommended daily doses (50). Consequently, the results pre-
sented here open new strategies in FRDA therapies.
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